AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. GRI
  4. [ARS] GRI Bio, Inc. SEC Filing

[ARS] GRI Bio, Inc. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
Rhea-AI Filing Summary
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreibe den folgenden Text um:
Positive
  • None.
Negative
  • None.
Riscrivi il testo seguente:
Reescribe el siguiente texto:
雼れ潓 韰嶌姢韸鸽ゼ 雼れ嫓 鞛戩劚頃橃劯鞖�:
R茅茅crivez le texte suivant :
Schreibe den folgenden Text um:
ARS - GRI Bio, Inc.

AG真人官方

ARS Filing - GRI Bio, Inc.

This filing is available as a PDF document.

Filing Type: ARS

Company: GRI Bio, Inc. (GRI)

Acceptance Date: 2025-07-11T16:20:46.000Z

Source:

Stock GRI logo
GRI Bio

NASDAQ:GRI

GRI Rankings

#10669 Ranked by Market Cap
N/A Ranked by Dividends

GRI Latest News

Jul 31, 2025
GRI Bio CEO, Marc Hertz, Participates in Virtual Investor 鈥淲hat This Means鈥� Segment
Jul 31, 2025
GRI Bio Reports 6-Week Interim Biomarker Data in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (鈥淚PF鈥�)聽
Jul 22, 2025
GRI Bio Participates in the Virtual Investor 鈥淲hat鈥檚 Your Story鈥� Summer Spotlight On-Demand Conference
Jul 1, 2025
GRI Bio Completes Enrollment in Phase 2a Study of GRI-0621 for the Treatment of Idiopathic Pulmonary Fibrosis (鈥淚PF鈥�)
Jun 26, 2025
GRI Bio鈥檚 GRI-0621 Demonstrates Encouraging Safety Results at Planned Interim 6-Week Analysis in Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (鈥淚PF鈥�)

GRI Latest SEC Filings

Jul 31, 2025
[8-K] GRI Bio, Inc. Reports Material Event
Jul 11, 2025
[DEF 14A] GRI Bio, Inc. Definitive Proxy Statement
Jun 26, 2025
[8-K] GRI Bio, Inc. Reports Material Event

GRI Stock Data

5.12M
2.50M
0.12%
2.51%
5.22%
Biotechnology
Pharmaceutical Preparations
United States
LA JOLLA